762
Participants
Start Date
September 12, 2018
Primary Completion Date
August 3, 2020
Study Completion Date
August 10, 2020
Opt-Out Protocol
Should an eligible patient pass the safety screen and be randomized to the intervention arm of the trial, the designated pharmacist will approach the patient's primary provider in charge of antibiotic decision-making The pharmacist will inform the provider the patient's antibiotics can be de-escalated unless the provider opts out.
Hospital of the University of Pennsylvania, Philadelphia
Pennsylvania Presbyterian Hospital, Philadelphia
Duke University, Durham
Wilson Medical Center, Wilson
Southeastern Regional Medical Center, Lumberton
Iredell Health System, Statesville
Piedmont Fayette Hospital, Fayetteville
Piedmont Newnan Hospital, Newnan
Piedmont Atlanta Hospital, Atlanta
Harvard Brigham and Women's Hospital, Boston
Lead Sponsor
Duke University
OTHER